Astellas Pharma Bets on Investment in Mexico and Opens New Offices

Astellas Pharma, a leading Japanese company, has entered the Mexican healthcare industry with an investment of $10 million.
Their new offices in Santa Fe focus on oncology and rare diseases.

The new offices are located in the Santa Fe corporate area. Photo: Astellas.

By: SiiLA News

06/28/2022

Discover the exciting arrival of Astellas Pharma, a prominent Japanese company, to the healthcare industry in Mexico. With an initial investment of approximately $10 million and the creation of high-value jobs, Astellas Pharma has launched its new offices in the corporate zone of Santa Fe, with a cutting-edge focus on areas such as oncology and rare diseases.

As a subsidiary of Astellas Pharma Inc., headquartered in Tokyo, Japan, the company is dedicated to addressing the unmet healthcare needs of Mexican patients through innovation. The inauguration of the new offices was a significant event, featuring representatives from the company at regional and global levels, industry leaders, medical associations, patient organizations, and the media.

The presence of the Japanese Ambassador to Mexico, Noriteru Fukushima, emphasized the importance of Astellas Pharma as a global pharmaceutical company and highlighted the diversity of the Mexican economy beyond the automotive sector.

Read the full article in Spanish

Latam

Mexico

Mexico City

Office

Market Analytics

Tenants In The Market

ABOUT SiiLA

Founded in 2015, SiiLA is the industry leading REsource for comprehensive commercial real estate market insights, news and events across Latin America. The SiiLA suite of innovative products drive greater accuracy, efficiency, and strategic advantages for top players in the commercial real estate industry.